Highbridge Capital Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-13,600
Closed -$78K 73
2019
Q3
$78K Sell
13,600
-75,400
-85% -$512K 0.01% 73
2019
Q2
$682K Sell
89,000
-14,200
-14% -$76.4K 0.05% 120
2019
Q1
$542K Buy
103,200
+27,800
+37% +$193K 0.02% 310
2018
Q4
$494K Buy
+75,400
New +$845K 0.01% 306
2015
Q4
Sell
-9,787
Closed -$307K 1731
2015
Q3
$307K Sell
9,787
-5,348
-35% -$261K ﹤0.01% 1221
2015
Q2
$732K Buy
15,135
+6,346
+72% +$267K 0.01% 828
2015
Q1
$381K Buy
+8,789
New +$316K 0.01% 1046
2014
Q4
Sell
-33,901
Closed -$601K 1376
2014
Q3
$601K Buy
33,901
+25,321
+295% +$517K 0.01% 809
2014
Q2
$207K Buy
+8,580
New +$174K ﹤0.01% 965

Other funds holding PGEN

Highbridge Capital Management's PGEN Position: Q2 2016 in Review

Highbridge Capital Management sold out of Precigen (PGEN) in Q2 2016, closing a stake of 8,254 shares — an estimated $277K sold.

Highbridge Capital Management first reported a position in PGEN in Q3 2014 and held it in 3 quarters. The position peaked at $324K in Q3 2015. 169 funds tracked by Wall St. Rank hold PGEN as of Q2 2016.

  • Highbridge Capital Management reported no remaining Precigen position as of Q2 2016 after selling out during the quarter.
  • Highbridge Capital Management sold 8,254 Precigen shares in Q2 2016, an estimated $277K.
  • Highbridge Capital Management first reported a position in Precigen in Q3 2014 and held it in 3 quarters.
  • Highbridge Capital Management's Precigen position peaked at $324K in Q3 2015.
  • 169 funds tracked by Wall St. Rank held Precigen as of Q2 2016.

Based on Highbridge Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.